(Q35823982)

10 August 2017

1 reference

title

The BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitus (English)

1 reference

10 August 2017

1 reference

Rebecca S Tirabassi

1

1 reference

10 August 2017

Joan F Flanagan

2

1 reference

10 August 2017

Tiangen Wu

3

1 reference

10 August 2017

Edward H Kislauskis

4

1 reference

10 August 2017

Paul J Birckbichler

5

1 reference

10 August 2017

Dennis L Guberski

6

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

45

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

292-302

1 reference

Perspectives on diabetic retinopathy

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Beta-cell rejuvenation with thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Restenosis after coronary angioplasty: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Case-control study of serum lipoprotein(a) and apolipoproteins A-I and B in stroke in the young.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

The challenge of type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Temporal variation in diabetic macular edema measured by optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Hyperglycemia and microvascular and macrovascular disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Essential hypertension is associated with decreased insulin clearance and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

The natural progression of autonomic neuropathy and autonomic function tests in a cohort of people with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the diabetes control and complications trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Better glycaemic control and risk reduction of diabetic complications in Type 2 diabetes: comparison with the DCCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Initial characterization of a rat model of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Care of the patient and management of complications after percutaneous coronary artery interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Renal structures in type 2 diabetic patients with elevated albumin excretion rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Percutaneous transluminal coronary angioplasty: what next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

New insights into the metabolic and molecular basis for diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Increases in renal epsilon-(gamma-glutamyl)-lysine crosslinks result from compartment-specific changes in tissue transglutaminase in early experimental diabetic nephropathy: pathologic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Pathogenesis of angiopathy in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Microvascular basement membranes in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Differing effects of antihypertensive agents on urinary albumin excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Metabolic abnormalities in the genetically obese and diabetic Otsuka Long-Evans Tokushima Fatty rat can be prevented and reversed by alpha-glucosidase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

Glucose control in type 1 diabetes: from conventional to intensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.45.3.292

21 January 2018

Identifiers

DOI

10.1093/ILAR.45.3.292

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bkolkvagezgkdngg3phvdfyini

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_bkolkvagezgkdngg3phvdfyini

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bkolkvagezgkdngg3phvdfyini

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/bkolkvagezgkdngg3phvdfyini

1 reference